Peptide-chlorambucil conjugates combat Pgp-dependent drug efflux

Sonali B. Fonseca, Shana O. Kelley

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Cancer drugs, such as the ovarian cancer drug adriamycin, are effective at slowing disease progression and improving remission rates in patients. However, drug resistance often arises, limiting the activity of these agents in some patients. In particular, efflux pumps, which export drugs out of cells, limit the efficacy of a variety of anticancer agents. While inhibitors to block these pumps currently exist, they are usually not used clinically because they alter other drug properties. Here, we report a novel inhibitor of drug efflux that only reduces pump activity temporarily. This decreases the risk that it will alter drug function and cause nonspecific toxicity. P-glycoprotein efflux pumps are commonly overexpressed by malignant cells and are a major contributing factor to the development of drug resistance. Many therapeutics containing basic nitrogens, hydrophobic character, or aromaticity are efficiently eliminated from cells, and Pgp inhibitors must often be coadministered to limit this process. However, currently available inhibitors often alter the pharmacokinetic profiles of therapeutics or increase off-target toxicity, limiting their clinical utility. Here, we report the development of a novel panel of peptide-chlorambucil conjugates capable of efficiently decreasing efflux of Pgp substrates. These conjugates selectively improve adriamycin toxicity and uptake for short, but not prolonged, periods reducing the risk of altered pharmacokinetics and off-target effects.

Original languageEnglish (US)
Pages (from-to)419-423
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume2
Issue number6
DOIs
StatePublished - Jun 9 2011
Externally publishedYes

Keywords

  • adriamycin
  • cell-penetrating peptide
  • chlorambucil
  • mitochondria-penetrating peptide
  • P-glycoprotein

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Peptide-chlorambucil conjugates combat Pgp-dependent drug efflux'. Together they form a unique fingerprint.

Cite this